APONTIS PHARM. AG ON
Share · DE000A3CMGM5 (XFRA)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of APONTIS PHARM. AG ON
No Price
Company Profile for APONTIS PHARM. AG ON Share
Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It develops, promotes, and sells a portfolio of single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prevention, as well as respiratory diseases and diabetes. The company was founded in 1946 is headquartered in Monheim am Rhein, Germany.
Company Data
Name APONTIS PHARM. AG ON
Company Apontis Pharma AG
Website
https://apontis-pharma.de
Primary Exchange 
Frankfurt
Frankfurt
ISIN DE000A3CMGM5
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Sascha Glanemann
Market Capitalization 92 Mio
Country Germany
Currency EUR
Employees 0,1 T
Address Alfred-Nobel-Str. 10, 40789 Monheim am Rhein
IPO Date 2021-05-11
Ticker Symbols
| Name | Symbol |
|---|---|
| Düsseldorf | APONTIM5.DUSB |
| Frankfurt | APPH.F |
| Hamburg | APONTIM5.HAMB |
| Quotrix | APONTIM5.DUSD |
| XETRA | APPH.DE |
More Shares
Investors who hold APONTIS PHARM. AG ON also have the following shares in their portfolio:
